Siren »

Crinetics Pharmaceuticals In shares owned by Siren

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Siren from 13F filings

Historical chart of Siren investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Siren

Quarter filed Position value Share count Share price at filing
2024-09-30 $67M 1.3M 51.10

More positions owned by Siren

Kymera Therapeutics (KYMR)
Beigene Sponsored Adr (BGNE)
Scholar Rock Hldg Corp (SRRK)
Bicara Therapeutics
Argenx SE Sponsored Adr (ARGX)
Crinetics Pharmaceuticals In (CRNX)
Avidity Biosciences Ord (RNA)
Apellis Pharmaceuticals (APLS)
Lexicon Pharmaceuticals Com New (LXRX)
Igm Biosciences (IGMS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Silence Therapeutics Ads (SLN)
Arrowhead Pharmaceuticals (ARWR)
WAVE Life Sciences SHS (WVE)

View all positions for Siren

Top funds holding Crinetics Pharmaceuticals In

BlackRock
BlackRock
Driehaus Capital Management
T. Rowe Price Associates
Vanguard Group
EcoR1 Capital
State Street Corporation
Jennison Associates
Paradigm Biocapital Advisors
Henderson Group
Point72 Asset Management
Geode Capital Management
Franklin Resources
Cormorant Asset Management
Siren

View all funds holding Crinetics Pharmaceuticals In